Introduction
Sample pretreatment is extremely important for biological analysis and purification of a target material. Solid-phase extraction (SPE) is widely used for sample pretreatment because of its ease of use, expediency, and solvent economy compared to other methods. [1] [2] [3] [4] [5] [6] C18 SPE sorbent is the most widely used SPE system for separation and purification. Usually, organic solvents or strong acids are used in pretreatment, but their use leads to protein denaturation. 7 Therefore, in this work, we aim at developing a novel SPE method that does not cause protein denaturation.
Poly(N-isopropylacrylamide) (PNIPAAm) is a well-known thermo-responsive polymer, which exhibits a reversible transition from a soluble to an insoluble state in aqueous solution in response to temperature changes across its lower critical solution temperature (LCST, 32 C). 8 PNIPAAm polymer chains are hydrophilic and hydrated in water below the LCST, and dehydrated and hydrophobic above the LCST. Taking advantage of this behavior, we have developed temperature-responsive chromatography systems based on a PNIPAAm-modified stationary phase. [9] [10] [11] [12] [13] While conventional chromatography uses reverse-phase columns and the partitioning properties are controlled by the composition ratio of organic solvent to water, in our temperature-responsive chromatography system, the partitioning properties are controlled by external temperature changes (hydrophilic-hydrophobic switching) using only aqueous solution as a mobile phase without any organic solvent. This system is superior to the conventional system in that biomolecules can be separated without any loss of bioactivity.
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Though there are some literature reports on temperatureresponsive chromatography, to the best of our knowledge, a temperature-responsive SPE system has not yet been reported.
In this study, we developed an SPE system utilizing a temperature-responsive hydrogel-modified sorbent with only aqueous solution as the eluent. Aminopropyl silica beads (average diameter, 40 -64 μm) were modified with PNIPAAmbased copolymer hydrogels with butyl methacrylate (BMA) and N,N-dimethylaminopropyl acrylamide (DMAPAAm, P(NIPAAm-co-BMA-co-DMAPAAm)) hydrogels. The hydrophobic and cationic properties of hydrogel-modified sorbents were controlled by changing the column temperature. By using SPE systems with these temperature-responsive hydrogel-modified sorbents, the separation of theophylline, phenytoin, and human serum albumin (HSA) via temperature switching was achieved. 300 Å for SPE/average diameter, 5 μm; pore size, 120 Å for HPLC) was purchased from ChemcoPlus Scientific Co., Ltd. (Tokyo, Japan). An Extract-Clean TM SPE 1.5 mL reservoir and frits for the reservoir were purchased from Grace (Deerfield, IL).
Preparation of initiator-immobilized silica beads
Initiator-immobilized silica beads were prepared according to a previously reported method.
13,14 V-501 (3.50 g, 12.5 mmol) and EEDQ (6.18 g, 25.0 mmol), an initiator and a condensing agent, respectively, were dissolved in 50 mL DMF in a roundbottomed flask. N2 gas was bubbled through the solution for 30 min. Then, 5.00 g aminopropyl silica beads (40 -64 μm) were immersed in the solution, and the mixture was degassed again for 30 min before the reaction was started. The reaction mixture was shaken for 17 h at 25 C. The modified silica beads were washed with ethanol and dried in vacuo overnight. Initiator-immobilized silica beads (5 μm) were also prepared by the same method.
Preparation of P(NIPAAm-co-BMA)-modified and P(NIPAAmco-BMA-co-DMAPAAm) hydrogel-modified silica beads
The P(NIPAAm-co-BMA) and P(NIPAAm-co-BMA-coDMAPAAm) hydrogel was prepared by a previously reported method. 13, 14 NIPAAm (4.72 g, 41.7 mmol), BMA (0.279 g, 1.97 mmol), and MBAAm (0.135 g, 0.876 mmol) for P(NIPAAm-co-BMA) hydrogel (molar ratio; NIPAAm:BMA = 95.5:4.5), and NIPAAm (4.07 g, 36.1 mmol), BMA (0.269 g, 1.90 mmol), DMAPAAm (0.657 g, 4.29 mmol), and MBAAm (0.135 g, 0.876 mmol) for P(NIPAAm-co-BMA-co-DMAPAAm) hydrogel (molar ratio; NIPAAm:BMA:DMAPAAm = 85.5:4.5:10) were dissolved in 100 mL ethanol in a roundbottomed flask. Initiator-immobilized silica beads (2.00 g, 40 -63 μm) were added to the solution. N2 gas was bubbled through the reaction mixture for 30 min, and polymerization was carried out for 15 h at 70 C. The PNIPAAm-based hydrogel-modified silica beads were filtered and washed with methanol at 25 C to remove any non-immobilized hydrogels and dried in vacuo overnight. P(NIPAAm-co-BMA) hydrogel for analysis of HSA was also prepared by the same method. 
Preparation of the SPE column with the hydrogel-modified sorbent
The outlet of the Extract-Clean TM SPE 1.5 mL reservoir was lidded with a frit. Then, 150 mg hydrogel-modified silica beads were suspended with 2 mL methanol/water (1:1) and poured into the Extract-Clean TM SPE 1.5 mL reservoir. The hydrogelmodified silica was washed with 200 mL water by aspiration. Finally, the inlet of the cartridge was lidded with a frit. It was stored under dry conditions until use.
Elution of phenytoin
Before each extraction, the P(NIPAAm-co-BMA-coDMAPAAm) and P(NIPAAm-co-BMA) SPE columns were conditioned with 15 mL of water at 4 or 40 C. Then, 1 mL of 2 μg/mL phenytoin dissolved in water at 4 or 40 C was loaded onto the hydrogel-modified sorbent, followed by multiple elution with individual portions of 1 mL of water at 4 or 40 C. The concentration of each elution fraction was determined by HPLC analysis. The analytical column used was Inertsil ® ODS-3 (50 × 2.1 mm; i.d., 2 μm). The column was connected to an HPLC system (Hitachi Model L-2160U intelligent pump, L-2400U UV-detector, and D-2000 Elite integrator, placed in L-2300 column oven at 40 C; Tokyo, Japan). Phenytoin was monitored at 220 nm at a flow rate of 0.4 mL/min with 20 mM ammonium acetate/CH3OH (1:1). The injection volume was 10 μL.
Elution of theophylline
Before each extraction, the P(NIPAAm-co-BMA-coDMAPAAm) SPE column was conditioned with 15 mL of 4 C water. Then, 1 mL of 2 μg/mL theophylline dissolved in water was loaded onto the hydrogel-modified sorbent, followed by multiple elution with individual portions of 1 mL water. The concentration of each elution was determined by HPLC analysis. The HPLC system comprised the Hitachi Model L-2160U intelligent pump, the L-2400U UV-detector, the D-2000 Elite integrator, and the Inertsil ® ODS-3 column (50 × 2.1 mm; i.d., 2 μm) placed in the L-2300 column oven at 40 C (Tokyo, Japan). Theophylline was monitored at 270 nm at a flow rate of 0.4 mL/min with 20 mM ammonium acetate/CH3OH (1:1). The injection volume was 10 μL.
Elution of HSA
Before each extraction, the P(NIPAAm-co-BMA-coDMAPAAm) and P(NIPAAm-co-BMA) SPE columns were conditioned with 15 mL of water at 40 or 4 C. Then, 1 mL of HSA (1 mg/mL) was loaded through the hydrogel-modified sorbents and fractionated (with 1 mL fractions). The recovery yields of HSA were determined by HPLC analysis. The analytical column was homemade P(NIPAAm-co-BMA)-modified silica (average diameter, 5 μm; pore size, 120 Å) packed into a stainless-steel column (150 × 4.6 mm i.d.). The column was connected to an HPLC system (Hitachi Model L-2160U intelligent pump; L-2400U UV-detector; D-2000 Elite integrator; L-2300 column oven at 15 C; Tokyo, Japan). HSA was monitored at 280 nm at a flow rate of 0.8 mL/min with 20 mM ammonium acetate. The injection volume was 10 μL.
Results and Discussion

Syntheses of PNIPAAm-based hydrogel layers on silica surfaces
The synthetic scheme of the temperature-responsive hydrogelmodified sorbents is shown in Scheme 1. While aminopropyl silica beads (average diameter, 3 or 5 μm) were used as the sorbent in the temperature-responsive chromatography in our previous work, 9-13 such precisely calibrated small silica particles are relatively expensive. An SPE cartridge is often used as a disposable pretreatment column. Therefore, relatively inexpensive aminopropyl silica beads (average diameter, 40 -64 μm) were selected for SPE sorbents. Hydrogels have been widely applied to the separation of biomolecules. [15] [16] [17] The method for preparing thermally responsive hydrogel-modified sorbents is relatively simple and easy compared with that of the PNIPAAm-based thermo-responsive terminally grafted sorbents. Additionally, the polymer layer formed on the silica beads showed resistance to an alkaline solution; 13 thus, hydrogel modification of the silica surface was selected for SPE sorbents that are used for the pretreatment of various samples. The cost of a PNIPAAm hydrogel-modified SPE column is comparable to that of a SepPak C18 (Waters) column, which is used for the pretreatment of various samples such as drugs in serum and the desalting of peptides. Therefore, it is expected that this SPE cartridge can be used as a disposable pretreatment column as well.
Elution of phenytoin
Phenytoin shown in Table 1 , an anti-epileptic drug, has a narrow therapeutic range and follows nonlinear kinetics at therapeutic concentrations. Therefore, it is important to monitor its serum levels. Figure 1 shows the elution profiles of phenytoin on P(NIPAAm-co-BMA) and P(NIPAAm-co-BMA-coDMAPAAm) hydrogel-modified SPE columns at 4 C using water as an eluent. Retention of phenytoin is clearly higher on the P(NIPAAm-co-BMA-co-DMAPAAm) SPE column, indicating that the introduction of DMAPAAm that works as the ion-exchange functional group was effective in the retention of phenytoin. Figures 2 and 3 show the elution profiles of phenytoin through a P(NIPAAm-co-BMA-co-DMAPAAm) SPE column at 4 and 40 C, and temperature switching from 4 to 40 C, respectively. At 4 C, 11 mL of water was needed to elute phenytoin, compared to 4 mL of water at 40 C. Since phenytoin is negatively charged in the presence of DMAPAAm, the driving force for the retention of phenytoin is likely the electrostatic interaction between phenytoin and the cationic DMAPAAm units of the hydrogel. At 4 C (below the LCST), the charged DMAPAAm appears on the hydrogel surface and interacts with phenytoin. In contrast, at 40 C (above the LCST), DMAPAAm's charge gets buried in the shrunk hydrogel, and therefore, Scheme 1 Synthetic scheme of temperature-responsive hydrogel-modified sorbents. Theophylline Log P = -0.02 pKa = 8.77 MW = 180.17 Fig. 1 Comparison of elution profiles of phenytoin on P(NIPAAmco-BMA-co-DMAPAAm) and P(NIPAAm-co-BMA) hydrogelmodified SPE columns. Load: 1 mL of 2 μg/mL phenytoin. Elution: 1 mL water at 4 C. Fig. 2 Comparison of elution profiles of phenytoin on a P(NIPAAmco-BMA-co-DMAPAAm) SPE column at 4 and 40 C. Load: 1 mL of 2 μg/mL phenytoin. Elution: 1 mL water.
phenytoin, which is not retained anymore, is eluted. This result indicates that the retention behavior of anionic samples can be controlled by altering the cationic copolymer composition of the hydrogel surface.
Elution of theophylline
Theophylline shown in Table 1 , a drug used in respiratory diseases, is a weakly basic drug and is positively charged in water. Because theophylline has a narrow therapeutic range and its effects may be reduced when used with phenytoin, it is important to monitor the serum levels of theophylline. Figure 4 shows the elution profile of theophylline as a cationic sample on the P(NIPAAm-co-BMA-co-DMAPAAm) SPE column with a recovery rate of 98.2%. Theophylline was not adsorbed to the P(NIPAAm-co-BMA-co-DMAPAAm) hydrogel-modified sorbent at 4 C. This is because of the electrostatic repulsion between theophylline and the charge of DMAPAAm, and it is considered that the anionic and cationic samples can be separated by using cationic copolymers such as polymer containing DMAPAAm.
Separation of human serum albumin with temperature and ionexchange switching
HSA (MW = 66.4 kDa, pI = 4.7 18 ) is the most abundant protein in human blood plasma and accounts for about 65% of the blood serum protein. Since albumin is basic, primarily acidic and neutral drugs will bind to it. Figure 5 shows the elution profiles of HSA on the P(NIPAAm-co-BMA) SPE column at 4 and 40 C with 0.9% NaCl aqueous solution as an eluent. HSA was not retained on the P(NIPAAm-co-BMA) hydrogel-modified SPE column under the conditions used. Figure 6 shows the elution profiles of HSA through the P(NIPAAm-co-BMA-co-DMAPAAm) SPE column at 4, 40 C, and temperature switching with the eluent changing from water to 0.9% NaCl aqueous solution. While the elution of HSA was not observed with water as an eluent, it was eluted with 0.9% NaCl aqueous solution. HSA, with an isoelectric point at 4.7, is negatively charged in water. Therefore, it is likely that ionic interactions between the negatively charged regions of HSA and positively charged amino moieties of DMAPAAm were present when using water as an eluent, and HSA was eluted by a cation exchange using an eluent with 0.9% NaCl aqueous solution. These results indicated that the elution of HSA can be controlled by ion-exchange switching. Figure 7 shows the elution profiles of a mixture of phenytoin, theophylline, and HSA through the P(NIPAAm-co-BMA-coDMAPAAm) SPE column with temperature switching from 4 to 40 C and eluent changing from water to 0.9% NaCl aqueous Fig. 3 Elution profile of phenytoin on a P(NIPAAm-co-BMA-coDMAPAAm) SPE column. Load: 1 mL of 2 μg/mL phenytoin. Elution: 1 mL water at 4 C from E1 to E3, 40 C from E4 to E8. Error bars representing mean + σ (n = 3). Fig. 4 Elution profile of theophylline on a P(NIPAAm-co-BMA-coDMAPAAm) SPE column. Load: 1 mL of 2 μg/mL theophylline. Elution: 1 mL water at 4 C from E1 to E3. solution. Theophylline, phenytoin, and HSA were eluted by 4 C water, 40 C water, and 4 C 0.9% NaCl aqueous solution, respectively. Using the same combination of temperature and eluent as was used for eluting the individual compounds, the mixture of the two drugs and HSA could be separated. As Fig. 8 shows, the total recovery rates were almost constant within the loading range of 1 -5 μg (phenytoin: 87.3%, theophylline: 96.6%).
Separation of a mixture of theophylline, phenytoin, and HSA
Conclusions
PNIPAAm-based thermo-responsive hydrogels were prepared with hydrophobic BMA and cationic DMAPAAm co-monomers and used as a stationary phase for temperature-responsive SPE systems, using only aqueous solution as an eluent. As the fabrication of one SPE cartridge was relatively inexpensive, it is expected that these cartridges can be used as a disposable pretreatment column. Phenytoin retention was controlled by temperature, while HSA retention was controlled by changing the eluent from water to 0.9% NaCl aqueous solution. Using a P(NIPAAm-co-BMA-co-DMAPAAm) hydrogel-modified SPE column, which has a cationic character, theophylline and phenytoin were separated from HSA. Separation modes by electrostatic interaction using a P(NIPAAm-co-BMA-coDMAPAAm) SPE column can be used for the separation of acidic and basic drugs as well as serum proteins. These features of the SPE system could provide new opportunities for the pretreatment of biological samples for measuring serum drug levels. Fig. 6 Elution profile of HSA on a P(NIPAAm-co-BMA-coDMAPAAm) SPE column. Load: 1 mL of 1 mg/mL HSA. Elution: 1 mL water at 4 C from E1 to E3, 40 C from E4 to E8, 0.9% NaCl aqueous solution at 4 C from E9 to E10. Fig. 8 Standard curve of theophylline and phenytoin on a P(NIPAAm-co-BMA-co-DMAPAAm) SPE column. Load: 1 mL of 1, 2, 5 μg/mL theophylline and phenytoin, and 1 mg/mL HSA. Elution: 1 mL water at 4 C from E1 to E3, 40 C from E4 to E8, 0.9% NaCl aqueous solution at 4 C from E9 to E10. Error bars representing mean ± σ (n = 3). Fig. 7 Elution profile of a mixture of theophylline, phenytoin, and HSA on a P(NIPAAm-co-BMA-co-DMAPAAm) SPE column. Load: 1 mL of 5 μg/mL theophylline and phenytoin, and 1 mg/mL HSA. Elution: 1 mL water at 4 C from E1 to E3, 40 C from E4 to E8, 0.9% NaCl aqueous solution at 4 C from E9 to E10.
